Tyra Change In Cash from 2010 to 2026
| TYRA Stock | USD 27.99 1.20 4.11% |
Change In Cash | First Reported 2020-03-31 | Previous Quarter -2.2 M | Current Value -36.5 M | Quarterly Volatility 79.2 M |
Check Tyra Biosciences financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Tyra Biosciences' main balance sheet or income statement drivers, such as Net Interest Income of 21.4 M, Depreciation And Amortization of 626.7 K or Interest Expense of 357.4 K, as well as many indicators such as Price To Sales Ratio of 0.0, Dividend Yield of 0.0 or PTB Ratio of 2.19. Tyra financial statements analysis is a perfect complement when working with Tyra Biosciences Valuation or Volatility modules.
Tyra | Change In Cash | Build AI portfolio with Tyra Stock |
Analyzing Tyra Biosciences's Change In Cash over time reveals critical patterns in financial health and operational efficiency. This metric helps investors evaluate trends, identify inflection points, and make informed decisions based on historical performance. Understanding how Change In Cash has evolved provides context for assessing Tyra Biosciences's current valuation and future prospects.
Latest Tyra Biosciences' Change In Cash Growth Pattern
Below is the plot of the Change In Cash of Tyra Biosciences over the last few years. It is Tyra Biosciences' Change In Cash historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Tyra Biosciences' overall financial position and show how it may be relating to other accounts over time.
| Change In Cash | 10 Years Trend |
|
Change In Cash |
| Timeline |
Tyra Change In Cash Regression Statistics
| Arithmetic Mean | 7,643,953 | |
| Geometric Mean | 8,859,978 | |
| Coefficient Of Variation | 1,155 | |
| Mean Deviation | 42,436,875 | |
| Median | (2,481,000) | |
| Standard Deviation | 88,279,800 | |
| Sample Variance | 7793.3T | |
| Range | 480.2M | |
| R-Value | 0.07 | |
| Mean Square Error | 8274.8T | |
| R-Squared | 0 | |
| Significance | 0.80 | |
| Slope | 1,183,729 | |
| Total Sum of Squares | 124693.2T |
Tyra Change In Cash History
About Tyra Biosciences Financial Statements
Tyra Biosciences stakeholders use historical fundamental indicators, such as Tyra Biosciences' Change In Cash, to determine how well the company is positioned to perform in the future. Although Tyra Biosciences investors may analyze each financial statement separately, they are all interrelated. For example, changes in Tyra Biosciences' assets and liabilities are reflected in the revenues and expenses on Tyra Biosciences' income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Tyra Biosciences. Please read more on our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Change In Cash | 30.6 M | 32.1 M |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Tyra Biosciences offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Tyra Biosciences' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Tyra Biosciences Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Tyra Biosciences Stock:Check out the analysis of Tyra Biosciences Correlation against competitors. For information on how to trade Tyra Stock refer to our How to Trade Tyra Stock guide.You can also try the Portfolio Diagnostics module to use generated alerts and portfolio events aggregator to diagnose current holdings.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Tyra Biosciences. If investors know Tyra will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. Comprehensive Tyra Biosciences assessment requires weighing all these inputs, though not all factors influence outcomes equally.
Understanding Tyra Biosciences requires distinguishing between market price and book value, where the latter reflects Tyra's accounting equity. The concept of intrinsic value - what Tyra Biosciences' is actually worth based on fundamentals - guides informed investors toward better entry and exit points. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Market sentiment, economic cycles, and investor behavior can push Tyra Biosciences' price substantially above or below its fundamental value.
Please note, there is a significant difference between Tyra Biosciences' value and its price as these two are different measures arrived at by different means. Investors typically determine if Tyra Biosciences is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. In contrast, Tyra Biosciences' trading price reflects the actual exchange value where willing buyers and sellers reach mutual agreement.